Robert Renninger insider trades: LeonaBio (LONA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | LONA | ↓ Sell | 906 | $5.37 | $5K | Direct | Mar 5, 2026 (1d) |
| Jan 2, 2026 | ATHA | ↓ Sell | 297 | $6.88 | $2K | Direct | Jan 5, 2026 (3d) |
| Jul 1, 2025 | ATHA | ↓ Sell | 2,897 | $0.29 | $850 | Direct | Jul 2, 2025 (1d) |
| Jan 2, 2025 | ATHA | ↓ Sell | 2,881 | $0.56 | $2K | Direct | Jan 3, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LONA insiders
Open-market trades in the last 12 months
About Robert Renninger's insider trades
Robert Renninger is Chief Financial Officer at LeonaBio (LONA). Since Jan 2, 2025, Robert has reported no open-market purchases and 4 sales worth $9K on SEC Form 4. In the last 12 months: 2 sales ($7K).
Their filings also include grants and awards (6 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LONA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.